EUVIMEDEUVIMED entdecken
Crossref

Investigation of the potential mechanisms associated with the effects of the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 on vascular endothelial injury

XuDong Cui, Qi Zhang, Jianfei Li, Zhifang Guan, Wangliang Zhu, Lidong Xu, Guojian Sun

Technology and Health Care · 19.11.2026

DOI: 10.1177/09287329261498663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology and Health Care, online erschienen am 19.11.2026. Verfasst von XuDong Cui und 6 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronary atherosclerotic heart disease is a major cardiovascular disease that poses a serious threat to human health. Quinazoline derivatives possess diverse biological activities and considerable structural modifiability, making them valuable candidates for drug development.

Objective

This study aimed to investigate the potential mechanism by which the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 protects against vascular endothelial injury.

Methods

Network pharmacology, single-cell transcriptomic analysis, and functional experiments were integrated to identify and prioritize a candidate functional target of KZL-064. An oscillatory shear stress-induced endothelial cell injury model was established to evaluate the protective effects of KZL-064. The functional involvement of the candidate target was further examined through HDAC1 overexpression and knockdown experiments.

Results

HDAC1 was identified as a prioritized candidate functional target potentially associated with the effects of KZL-064 and was significantly upregulated in atherosclerotic lesions. HDAC1 overexpression aggravated endothelial injury, whereas KZL-064 markedly alleviated oscillatory shear stress-induced damage. This protective effect was substantially diminished following HDAC1 knockdown. Further analysis indicated that KZL-064 was associated with the partial restoration of endothelial homeostasis and the modulation of inflammatory and cell cycle-related genes in an HDAC1-related context.

Conclusion

KZL-064 alleviates OSS-induced endothelial cell injury and is associated with modulation of inflammatory and cell cycle-related genes. HDAC1 was identified as a prioritized candidate functional target potentially involved in the action of KZL-064. These findings suggest potential relevance to atherosclerosis-associated endothelial dysfunction, while direct HDAC1 binding, enzymatic inhibition, target selectivity, and in vivo anti-atherosclerotic efficacy remain to be established.

Förderung

  • Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences

Zitieren

APA

Cui, X., Zhang, Q., Li, J., Guan, Z., Zhu, W., Xu, L., & Sun, G. (2026). Investigation of the potential mechanisms associated with the effects of the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 on vascular endothelial injury. Technology and Health Care. https://doi.org/10.1177/09287329261498663

Vancouver

Cui X, Zhang Q, Li J, Guan Z, Zhu W, Xu L, et al. Investigation of the potential mechanisms associated with the effects of the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 on vascular endothelial injury. Technology and Health Care. 2026. doi:10.1177/09287329261498663

BibTeX
@article{Cui2026,
  author = {Cui, XuDong and Zhang, Qi and Li, Jianfei and Guan, Zhifang and Zhu, Wangliang and Xu, Lidong and Sun, Guojian},
  title = {Investigation of the potential mechanisms associated with the effects of the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 on vascular endothelial injury},
  journal = {Technology and Health Care},
  year = {2026},
  doi = {10.1177/09287329261498663}
}
Kostenlos starten →